Zentalis (ZNTL) Locks In Its Cancer Drug Dose; Jefferies Raises the Target

Zentalis announced successful an April 9 property merchandise that it had selected 400mg erstwhile regular connected a five-days-on, two-days-off docket arsenic the optimal monotherapy dose of azenosertib for patients with Cyclin E1-positive platinum-resistant ovarian cancer. The institution explained that this dose was arrived astatine aft a prespecified interim information investigation from the DENALI Part 2a study.

Zentalis CEO Julie Eastland described the confirmation of azenosertib’s monotherapy dose arsenic a pivotal milestone that puts the institution firmly connected way toward regulatory approval. She noted that the institution is already moving beyond the objective trials themselves. They are gathering retired its commercialized team, expanding manufacturing capacity, and processing the companion diagnostic needed to place eligible patients.

With dose enactment present confirmed, Jefferies is watching 2 near-term information points that could displacement the communicative further. The archetypal is Phase 2 efficacy information from the afloat DENALI trial, which Zentalis expects to stock by year-end 2026. The 2nd information constituent is the confirmatory Phase 3 study, ASPENOVA, which is connected way to statesman enrolling patients successful Q2 2026.

Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) is simply a clinical-stage biotechnology company. It focuses connected processing small-molecule therapies targeting cardinal biologic pathways successful cancer. Its pb campaigner is azenosertib, a WEE1 inhibitor presently successful late-stage objective improvement for ovarian crab and different tumor types.

While we admit the imaginable of ZNTL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: David Abrams’ Hedge Fund Is Betting On These 8 Stocks and 10 Best Energy Storage Stocks to Buy According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.